HCP, Inc. (NYSE:HCP) announced a quarterly dividend on Wednesday, October 23rd, RTT News reports. Shareholders of record on Monday, November 4th will be paid a dividend of 0.37 per share by the real estate investment trust on Tuesday, November 19th. This represents a $1.48 annualized dividend and a yield of 3.94%.
Shares of HCP opened at $37.59 on Friday. The business’s 50-day moving average is $35.83 and its two-hundred day moving average is $32.99. The company has a market capitalization of $18.63 billion, a P/E ratio of 20.65, a P/E/G ratio of 7.06 and a beta of 0.23. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.90 and a current ratio of 0.90. HCP has a fifty-two week low of $26.18 and a fifty-two week high of $37.93.
HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.46). The company had revenue of $489.15 million for the quarter, compared to analyst estimates of $444.67 million. HCP had a return on equity of 15.54% and a net margin of 53.57%. HCP’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.45 earnings per share. Analysts forecast that HCP will post 1.75 EPS for the current year.
Several equities research analysts have weighed in on the company. Barclays increased their price target on HCP from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. TheStreet raised shares of HCP from a “c+” rating to a “b-” rating in a research note on Friday, August 2nd. ValuEngine lowered shares of HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $35.00 to $38.00 in a research note on Tuesday, October 8th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. HCP currently has an average rating of “Buy” and a consensus target price of $36.10.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Outstanding Shares, Buying and Selling Stocks
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.